Home / Investors Information / EDAP to Collaborate on Use of HIFU in Cancer Drug Delivery Following Successful Feasibility Study Read more about EDAP to Collaborate on Use of HIFU in Cancer Drug Delivery Following Successful Feasibility Study EDAP Schedules Webcast and Conference Call for Third Quarter 2010 Results Read more about EDAP Schedules Webcast and Conference Call for Third Quarter 2010 Results EDAP Successfully Completes Preliminary Trial of HIFU in Liver Cancer Read more about EDAP Successfully Completes Preliminary Trial of HIFU in Liver Cancer EDAP Expands Japan Sales Force Read more about EDAP Expands Japan Sales Force EDAP to Present at Rodman & Renshaw Annual Global Investment Conference Read more about EDAP to Present at Rodman & Renshaw Annual Global Investment Conference EDAP Reports Publication of Long-Term Clinical Results for Largest Cohort of Ablatherm-HIFU Patients Read more about EDAP Reports Publication of Long-Term Clinical Results for Largest Cohort of Ablatherm-HIFU Patients EDAP Media Interview Highlights Prostate Cancer Read more about EDAP Media Interview Highlights Prostate Cancer EDAP Heightens Participation in Global Urology Congresses Read more about EDAP Heightens Participation in Global Urology Congresses EDAP Expands Ablatherm-HIFU Into China by Entering Exclusive Distribution Agreement Read more about EDAP Expands Ablatherm-HIFU Into China by Entering Exclusive Distribution Agreement EDAP Reports Second Quarter 2010 Financial Results Read more about EDAP Reports Second Quarter 2010 Financial Results Pagination First page « First Previous page ‹ Previous … Page 34 Page 35 Page 36 Page 37 Current page 38 Page 39 Page 40 Page 41 Page 42 … Next page Next › Last page Last » Subscribe to
EDAP to Collaborate on Use of HIFU in Cancer Drug Delivery Following Successful Feasibility Study Read more about EDAP to Collaborate on Use of HIFU in Cancer Drug Delivery Following Successful Feasibility Study
EDAP Schedules Webcast and Conference Call for Third Quarter 2010 Results Read more about EDAP Schedules Webcast and Conference Call for Third Quarter 2010 Results
EDAP Successfully Completes Preliminary Trial of HIFU in Liver Cancer Read more about EDAP Successfully Completes Preliminary Trial of HIFU in Liver Cancer
EDAP to Present at Rodman & Renshaw Annual Global Investment Conference Read more about EDAP to Present at Rodman & Renshaw Annual Global Investment Conference
EDAP Reports Publication of Long-Term Clinical Results for Largest Cohort of Ablatherm-HIFU Patients Read more about EDAP Reports Publication of Long-Term Clinical Results for Largest Cohort of Ablatherm-HIFU Patients
EDAP Media Interview Highlights Prostate Cancer Read more about EDAP Media Interview Highlights Prostate Cancer
EDAP Heightens Participation in Global Urology Congresses Read more about EDAP Heightens Participation in Global Urology Congresses
EDAP Expands Ablatherm-HIFU Into China by Entering Exclusive Distribution Agreement Read more about EDAP Expands Ablatherm-HIFU Into China by Entering Exclusive Distribution Agreement
EDAP Reports Second Quarter 2010 Financial Results Read more about EDAP Reports Second Quarter 2010 Financial Results
